Eisai, Nitto Denko to Co-develop Transdermal Formulation of Alzheimer's Disease Agent ARICEPT.
Tokyo, Japan, May 11, 2006 - (JCN) - Eisai announced on May 10 that it has signed a joint research agreement with Nitto Denko.Under the agreement terms, the two companies will collaborate in developing a transdermal formulation (adhesive tape) of ARICEPT, an agent for treating Alzheimer's disease.
Nitto Denko, a Japanese leading liquid-crystal film manufacturer, has established various methods for drug formulation design. In particular, the company retains expertise in synthesizing adhesive materials suitable for controlled release.
Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
 Printer friendly
 Cite/link
 Email
 Feedback
| |
| Publication: | JCNN News Summaries |
|---|---|
| Geographic Code: | 9JAPA |
| Date: | May 11, 2006 |
| Words: | 86 |
| Previous Article: | Novartis Pharma, Chugai Pharmaceutical to Ship Agent for Postmenopausal Breast Cancer. |
| Next Article: | AnGes MG Announces Results of Phase I Clinical Trial of HGF Gene Medicine. |